RECORDED WEBINAR
OVERVIEW
Our panelists discuss diabetes management strategies to help you enhance your ability to prescribe optimal treatment therapies and medical interventions for individuals living with type 2 diabetes. Following the presentation, speakers host Q&A session and showcase four case studies to explore treatment decision making related to real-world clinical cases.
LEARNING OBJECTIVES
Review the use of glucose-lowering medication for microvascular and macrovascular risk reduction.
Insights into agent-specific considerations as they relate to diabetes’ clinical course among currently available SGLT-2 inhibitors, GLP-1 receptor agonists, dual GIP-GLP-1 receptor agonists, and other medications.
Identification of strategies to remove barriers to guideline-directed therapy.
CREDITS
1.5 Free CE (CME, ABIM-MOC, ACPE, ANCC, AAPA, CDR, COP)
EXPIRATION DATE
December 31, 2024
Davida Kruger, NP Nurse PractitionerDivision of Endocrinology Henry Ford Health System
Richard Pratley, MDMedical Director at the AdventHealth Diabetes Institute, Senior Investigator, Diabetes Program Lead at the Translational Research Institute
Curtis Triplitt, PharmD, CDE Associate Professor/Clinical Department of Medicine Division of Diabetes UT Health
This activity is supported by an educational grant from Lilly.
Note: You do not need to be an ADA professional member to access our free continuing education programs. Simply create a free account and start exploring 70+ free CE courses. Login to get started!